Keyphrases
% Protection
11%
Adherence Inhibition
11%
Adhesin
44%
Adverse Effects
11%
Antibody Response
11%
Broadly Protective
22%
Challenge Model
11%
Cholera Toxin
11%
Developing Countries
11%
Diarrhea
100%
E. Coli Bacteria
11%
Enterotoxicity
11%
Enterotoxigenic
100%
Enterotoxigenic Escherichia Coli
100%
Escherichia Coli Diarrhea
11%
Escherichia Coli Strains
33%
Escherichia Coli Vaccines
22%
Fusion Antigen
22%
Fusion Strategy
11%
Heat-labile Toxin
22%
Heat-stable Toxin
11%
Immunogenic
22%
Immunogenicity
100%
Injectable Vaccine
11%
International Travellers
11%
Intramuscularly
11%
MecVax
100%
Moderate to Severe
11%
Multi-epitope
22%
Multivalent
100%
Novel Epitopes
11%
Protective Antibodies
33%
Protein-based
11%
Severe Cases
11%
Toxoid Fusion
22%
Vaccine Candidate
100%
Vaccine Development
11%
Vaccinology
11%
Virulence
11%
Watery Diarrhea
11%
Pharmacology, Toxicology and Pharmaceutical Science
Adhesin
44%
Cholera Toxin
11%
Diarrhea
100%
Enterotoxigenic Escherichia Coli
100%
Epitope
11%
Escherichia coli
55%
Escherichia Coli Vaccine
22%
Gastrointestinal Toxicity
11%
Immunogenicity
100%
Toxoid
22%
Vaccine Development
11%
Immunology and Microbiology
Antibody Response
11%
Cholera Toxin
11%
Enterotoxigenic Escherichia Coli
100%
Epitope
11%
Escherichia coli
55%
Escherichia Coli Vaccine
22%
Immunogenicity
100%
Neutralization
11%
Toxoid
22%
Vaccinology
11%